| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0017 | 1 |